Macrolide Antibiotics in Paediatric Infectious Diseases

@article{Guay1996MacrolideAI,
  title={Macrolide Antibiotics in Paediatric Infectious Diseases},
  author={Dr David R. P. Guay},
  journal={Drugs},
  year={1996},
  volume={51},
  pages={515-536}
}
Erythromycin and other macrolides have enjoyed a renaissance in the 1970s, 1980s and 1990s secondary to the discovery of ‘new’ pathogens such as Chlamydia, Legionella, Campylobacter and Mycoplasma spp. Erythromycin is an important therapeutic agent in the paediatric age group for several reasons: (a) it exhibits proven efficacy for a wide range of infections (upper and lower respiratory tract infections, skin/skin structure infections, prophylaxis of endocarditis/acute rheumatic fever… CONTINUE READING
9 Citations
200 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 200 references

Azithromycin ototoxicity in HIV patients

  • A Tseng, L Dolovich, I. Salit
  • [abstract no. LMI9]. 35th Interscience Conference…
  • 1995

Chlamydiae as pathogens

  • A Oehme, PB Musholt, K. Dreesbach
  • Am Fam Phys
  • 1994

Decline of erythromycin resistance of group A f 3 - hemolytic streptococci in Ja

  • JW Bass, ME Weisse, MR Plymyer
  • Arch Pediatr Adolesc Med
  • 1994

Similar Papers

Loading similar papers…